Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 7, 2006, Pages 1007-1016

  Gilman, J ^a   Shanahan, F ^a,b   Cashman, K D ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; AGE DISTRIBUTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; BONE ATROPHY; BONE TURNOVER; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOPENIA; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SEX DIFFERENCE; ULCERATIVE COLITIS; UNIVERSITY HOSPITAL;

ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; COLITIS, ULCERATIVE; COLLAGEN TYPE I; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; OSTEOCALCIN; OSTEOGENESIS; PARATHYROID HORMONE; PEPTIDES; VITAMIN D;

EID: 33645045895     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02835.x     Document Type: Article

References (49)

1. Ekbom A The Epidemiology of IBD. A lot of data but little knowledge. How shall we proceed Inflamm Bowel Dis 2004 10 S32 4
2. Shanahan F Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics Gastroenterology 2001 120 622 35
3. Bernstein CN Leslie WD Review article: Osteoporosis and inflammatory bowel disease Aliment Pharmacol Ther 2004 19 941 52
4. Vestergaard P Bone loss associated with gastrointestinal disease: prevalence and pathogenesis Eur J Gastroenterol Hepatol 2003 15 851 6
5. van Staa TP Cooper C Brusse LS Leufkens H Javaid MK Arden NK Inflammatory bowel disease and the risk of fracture Gastroenterology 2003 125 1591 7
6. Trebble TM Wootton SA Stroud MA et al. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status Aliment Pharmacol Ther 2004 19 1063 71
7. Bernstein CN Seeger LL Anton PA et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study Aliment Pharmacol Ther 1996 10 777 86
8. Silvennoinen J Lamberg-Allardt C Karkkainen M et al. Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease J Intern Med 1996 240 285 92
9. Scott EM Gaywood I Scott BB Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology Gut 2000 46 S1 S8
10. Arnaud SB Goldsmith RS Lambert PW et al. 25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man Proc Soc Exp Biol Med 1975 149 570 2
11. Haderslev KV Jeppesen PB Sorensen HA et al. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection Gut 2003 52 653 8
12. Duggan P O'Brien M Kiely M McCarthy J Shanahan F Cashman KD Vitamin K status in patients with Crohn's disease and relationship to bone turnover Am J Gastroenterol 2004 99 2178 85
13. Schoon EJ Müller MCA Vermeer C Schurgers LJ Brummer R-JM Stockbrügger RW Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease Gut 2001 48 473 7
14. Watts NB Clinical utility of biochemical markers of bone remodeling Clin Chem 1999 45 1359 68
15. Silvennoinen JA Risteli L Karttunen TJ Risteli J Increased degradation of type I collagen in patients with inflammatory bowel disease Gut 1996 38 223 8
16. Bischoff SC Herrmann A Goke M Manns MP von zur Muhlen A Brabant G Altered bone metabolism in inflammatory bowel disease Am J Gastroenterol 1997 92 1157 63
17. Bjarnason I Macpherson A Mackintosh C Buxton-Thomas M Forgacs I Moniz C Reduced bone density in patients with inflammatory bowel disease Gut 1997 40 228 33
18. Robinson RJ Iqbal SJ Abrams K Al-Azzawi F Mayberry JF Increased bone resorption in patients with Crohn's disease Aliment Pharmacol Ther 1998 12 699 705
19. Schulte C Dignass AU Mann K Goebell H Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease Inflamm Bowel Dis 1998 4 268 75
20. Schoon EJ Geerling BG Van Dooren IM et al. Abnormal bone turnover in long-standing Crohn's disease in remission Aliment Pharmacol Ther 2001 15 783 92
21. Ardizzone S Bollani S Bettica P Bevilacqua M Molteni P Bianchi Porro G Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis J Intern Med 2000 247 63 70
22. Miheller P Toth M Molnar E et al. Serum bone marker measurements in bone metabolism disorders associated with inflammatory bowel diseases Orv Hetil 2001 142 1557 60
23. Martin A Fries W Luisetto G et al. Bone density and calcium metabolism in patients with long-standing quiescent Crohn's disease Eur J Gastroenterol Hepatol 1994 6 611 6
24. McKenna MJ Differences in vitamin D status between countries in young adults and the elderly Am J Clin Nutr 1992 93 69 77
25. Zittermann A Vitamin D in preventive medicine: are we ignoring the evidence Br J Nutr 2003 89 552 72
26. Vieth R Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety Am J Clin Nutr 1999 69 842 56
27. Faust D Menge F Armbruster FP Lembcke B Stein J Increased serum bone sialoprotein concentrations in patients with Crohn's disease Z Gastroenterol 2003 41 243 7
28. Tajika M Matsuura A Nakamura T et al. Risk factors for vitamin D deficiency in patients with Crohn's disease J Gastroenterol 2004 39 527 33
29. Harries AD Brown R Heatley RV Williams LA Woodhead S Rhodes J Vitamin D status in Crohn's disease: association with nutrition and disease activity Gut 1985 26 1197 203
30. Driscoll RH Jr. Meredith SC Sitrin M Rosenberg IH Vitamin D deficiency and bone disease in patients with Crohn's disease Gastroenterology 1982 83 1252 8
31. Andreassen H Rix M Brot C Eskildsen P Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease Scand J Gastroenterol 1998 33 1087 93
32. Dresner-Pollak R Karmeli F Eliakim R Ackerman Z Tabb K Rachmilewitz D Femoral neck osteopenia in patients with inflammatory bowel disease Am J Gastroenterol 1998 93 1483 90
33. Lo CW Paris PW Clemens TL Nolan J Holick MF Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes Am J Clin Nutr 1985 42 644 9
34. Freaney R McBrinn Y McKenna MJ Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency Am J Clin Nutr 1993 58 187 91
35. Vogelsang H Klamert M Resch H Ferenci P Dietary vitamin D intake in patients with Crohn's disease Wien Klin Wochenschr 1995 107 578 81
36. McCarthy D Duggan P O'Brien M et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease Aliment Pharmacol Ther 2005 21 1073 83
37. Jahnsen J Falch JA Mowinckel P Aadland E Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease Scand J Gastroenterol 2002 37 192 9
38. Ovesen L Andersen R Jakobsen J Geographical differences in vitamin D status, with particular reference to European countries Proc Nutr Soc 2003 62 813 21
39. Krasinski SD Russell RM Furie BC et al. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders Am J Clin Nutr 1985 41 639 43
40. Sokoll LJ Sadowski JA Comparison of biochemical indexes for assessing vitamin K status in a healthy adult population Am J Clin Nutr 1996 63 566 73
41. Institute of Medicine Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc Washington, DC, USA National Academy Press 2001
42. Szulc P Meunier PJ Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease Lancet 2001 357 1995 6
43. Weber P Vitamin K and bone health Nutrition 2001 17 880 8
44. Szulc P Chapuy MC Meunier PJ et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women J Clin Invest 1993 91 1769 74
45. Rosen HN Dresner-Pollak R Moses AC et al. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover Calcif Tissue Int 1994 54 26 9
46. Dresner-Pollak R Karmeli F Eliakim R et al. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease Am J Gastroenterol 2000 95 699 704
47. Riggs BL Melton LJ III. O'Fallon WM Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy Bone 1996 18 S197 201
48. Parfitt AM Gallagher JC Heaney RP Johnston CC Neer R Whedon GD Vitamin D and bone health in the elderly Am J Clin Nutr 1982 36 1014 31
49. Silvennoinen JA Karttunen TJ Niemelä SE et al. A controlled study of bone mineral density in patients with inflammatory bowel disease Gut 1995 37 71 6